Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Computerized surveillance of adverse drug events in hospital patients.

Classen DC, Pestotnik SL, Evans RS, Burke JP.

JAMA. 1991 Nov 27;266(20):2847-51. Erratum in: JAMA 1992 Apr 8;267(14):1922.

PMID:
1942452
2.

A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting.

Handler SM, Altman RL, Perera S, Hanlon JT, Studenski SA, Bost JE, Saul MI, Fridsma DB.

J Am Med Inform Assoc. 2007 Jul-Aug;14(4):451-8. Epub 2007 Apr 25. Review. Erratum in: J Am Med Inform Assoc. 2007 Sep-Oct;14(5):686.

3.

Potential risks and prevention, Part 4: Reports of significant adverse drug events.

Kelly WN.

Am J Health Syst Pharm. 2001 Aug 1;58(15):1406-12. Review.

PMID:
11494785
4.

Methods for assessing the preventability of adverse drug events: a systematic review.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

Drug Saf. 2012 Feb 1;35(2):105-26. doi: 10.2165/11596570-000000000-00000. Review.

PMID:
22201475
5.

Adverse drug events and medication errors in Australia.

Runciman WB, Roughead EE, Semple SJ, Adams RJ.

Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. Review.

6.

The epidemiology of preventable adverse drug events: a review of the literature.

von Laue NC, Schwappach DL, Koeck CM.

Wien Klin Wochenschr. 2003 Jul 15;115(12):407-15. Review.

PMID:
12918183
7.

Principles of signal detection in pharmacovigilance.

Meyboom RH, Egberts AC, Edwards IR, Hekster YA, de Koning FH, Gribnau FW.

Drug Saf. 1997 Jun;16(6):355-65. Review.

PMID:
9241490
8.

Adverse drug events as a cause of hospitalization in older adults.

Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A.

Drug Saf. 2012 Jan;35 Suppl 1:29-45. doi: 10.1007/BF03319101. Review.

PMID:
23446784
9.

Pilot testing of checklists to discern adverse drug reactions and adverse drug events.

Chen AM, Kiersma ME, Shepler BM, Murawski MM.

J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):61-9. doi: 10.1331/JAPhA.2013.11196. Review.

PMID:
23636158
10.

Origin of Adverse Drug Events in U.S. Hospitals, 2011: Statistical Brief #158.

Weiss AJ, Elixhauser A, Bae J, Encinosa W.

Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Health Care Policy and Research (US); 2006 Feb-.
2013 Jul.

11.

Characteristics of Adverse Drug Events Originating During the Hospital Stay, 2011: Statistical Brief #164.

Weiss AJ, Elixhauser A.

Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Health Care Policy and Research (US); 2006 Feb-.
2013 Oct.

12.

Improving postapproval drug safety surveillance: getting better information sooner.

Hennessy S, Strom BL.

Annu Rev Pharmacol Toxicol. 2015;55:75-87. doi: 10.1146/annurev-pharmtox-011613-135955. Epub 2014 Sep 25. Review.

13.

Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting.

Seger AC, Gandhi TK, Hope C, Overhage JM, Murray MD, Weber D, Fiskio J, Teal E, Bates DW.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

14.

The medication minefield: using computerized decision support systems to reduce preventable adverse drug events and hospitalizations.

Bernstein R, Kogan P, Collins A.

J Ambul Care Manage. 2014 Jul-Sep;37(3):226-40. doi: 10.1097/JAC.0000000000000033. Review.

PMID:
24887524
15.

Mechanisms of unpredictable adverse drug reactions.

Rieder MJ.

Drug Saf. 1994 Sep;11(3):196-212. Review.

PMID:
7811401
16.

Linking laboratory and medication data: new opportunities for pharmacoepidemiological research.

ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, van Solinge WW.

Clin Chem Lab Med. 2007;45(1):13-9. Review.

PMID:
17243908
17.

How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?

Gentry CA, Rodvold KA.

Drug Saf. 1995 Jun;12(6):359-63. Review. No abstract available.

PMID:
8527010
Items per page

Supplemental Content

Write to the Help Desk